FAGRON N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.24 EUR | -0.22% |
|
+3.40% | +9.81% |
| 04-11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
| 04-11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.43B | ||||||
| 681B | ||||||
| 556B | ||||||
| 361B | ||||||
| 325B | ||||||
| 285B |
- Stock Market
- Equities
- FAGR Stock
- Charts Fagron N.V.
- Sector Chart
